Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cancer metastasis

Aneuploidy-driven vulnerabilities in breast cancer metastasis

A study reveals how chromosomal instability and resultant TP53 loss enhance fatty acid metabolism to drive breast cancer brain metastasis. This metabolic dependency provides new insights into therapeutic vulnerabilities of aneuploid tumors.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Loss of chromosome 17p drives fatty acid-dependent breast cancer brain metastasis.

References

  1. Ben-David, U. & Amon, A. Nat. Rev. Genet. 21, 44–62 (2020).

    Article  CAS  PubMed  Google Scholar 

  2. Bakhoum, S. F. & Cantley, L. C. Cell 174, 1347–1360 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Laue, K. et al. Nat. Genet. https://doi.org/10.1038/s41588-025-02446-1 (2025).

    Article  PubMed  Google Scholar 

  4. Burrell, R. A., McGranahan, N., Bartek, J. & Swanton, C. Nature 501, 338–345 (2013).

    Article  CAS  PubMed  Google Scholar 

  5. Nguyen, B. et al. Cell 185, 563–575.e11 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Min, J.-Y. & Kim, D.-H. Int. J. Mol. Sci. 24, 8951 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Che, G. et al. Clin. Transl. Med. 14, e1587 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Schwab, A. et al. Nat. Cell Biol. 26, 1470–1481 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Kelly, W. et al. Clin. Cancer Res. 29, 2419–2425 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Nuber, S. et al. Neurotherapeutics 19, 1018–1036 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Katoh, Y. et al. J. Immunother. Cancer 10, e004616 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  12. Tzeng, S.-F. et al. Cancer Discov. 15, 1676–1696 (2025).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Davoli, T., Uno, H., Wooten, E. C. & Elledge, S. J. Science 355, eaaf8399 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  14. Al-Rawi, D. H., Lettera, E., Li, J., DiBona, M. & Bakhoum, S. F. Nat. Rev. Clin. Oncol. 21, 645–659 (2024).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Samuel F. Bakhoum.

Ethics declarations

Competing interests

S.F.B. is a co-founder, chief scientific officer and a member of the board of directors at Volastra Therapeutics Inc., where he owns equity and from which he receives compensation. He also serves on the scientific advisory board of Meliora Therapeutics and Arinale Biosciences Inc. The work presented herein is unrelated to these affiliations, and these entities had no role in the conception, conduct or reporting of this research.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bakhoum, S.F. Aneuploidy-driven vulnerabilities in breast cancer metastasis. Nat Genet 58, 14–15 (2026). https://doi.org/10.1038/s41588-025-02444-3

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41588-025-02444-3

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer